Xilio Historical Balance Sheet

XLO Stock

USD 0.88 0.01 1.12%

Trend analysis of Xilio Development balance sheet accounts such as Total Assets of 113.8 M, Short Long Term Debt Total of 14.7 M, Other Current Liabilities of 10.9 M or Total Current Liabilities of 17 M provides information on Xilio Development's total assets, liabilities, and equity, which is the actual value of Xilio Development to its prevalent stockholders. By breaking down trends over time using Xilio Development balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Xilio Development latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Xilio Development is a good buy for the upcoming year.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xilio Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.

About Xilio Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Xilio Development at a specified time, usually calculated after every quarter, six months, or one year. Xilio Development Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Xilio Development and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Xilio currently owns. An asset can also be divided into two categories, current and non-current.

Xilio Development Balance Sheet Chart

At this time, Xilio Development's Property Plant And Equipment Net is very stable compared to the past year. As of the 26th of November 2024, Non Current Assets Total is likely to grow to about 15.5 M, while Other Current Liabilities is likely to drop about 10.9 M.

Short Long Term Debt Total Other Current Liab Total Current Liabilities Other Liab

Add Fundamental

Total Current Liabilities

Total Current Liabilities is an item on Xilio Development balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Xilio Development are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Xilio Development's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Xilio Development current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xilio Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.At this time, Xilio Development's Property Plant And Equipment Net is very stable compared to the past year. As of the 26th of November 2024, Non Current Assets Total is likely to grow to about 15.5 M, while Other Current Liabilities is likely to drop about 10.9 M.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	20.5M	19.9M	11.5M	14.7M
Total Assets	218.1M	139.2M	60.9M	113.8M

Short Long Term Debt Total Total Assets

Xilio Development balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.15	0.31	0.35	0.96	0.68	0.83	0.61	-0.96	-0.47	-0.05	0.95	0.6	0.01	0.84	-0.22	0.95	-0.23	-0.69	0.37	0.94	0.68	-0.7	0.83	0.33	0.95
Short Long Term Debt Total	0.15		-0.31	-0.1	-0.08	-0.5	-0.39	0.05	-0.23	0.61	0.82	0.3	0.07	-0.16	0.27	0.59	0.3	0.41	0.5	-0.37	-0.05	-0.33	0.55	-0.4	0.63	0.29
Other Current Liab	0.31	-0.31		0.95	0.43	0.76	0.59	0.86	-0.22	-0.84	0.14	0.19	0.85	-0.57	0.2	-0.81	0.19	-0.33	-0.71	0.97	0.57	0.86	-0.59	0.59	0.08	0.19
Total Current Liabilities	0.35	-0.1	0.95		0.43	0.7	0.52	0.91	-0.25	-0.78	0.28	0.23	0.9	-0.77	0.14	-0.8	0.23	-0.33	-0.66	0.88	0.53	0.82	-0.53	0.52	0.09	0.23
Total Stockholder Equity	0.96	-0.08	0.43	0.43		0.82	0.94	0.6	-0.94	-0.64	-0.2	0.91	0.58	-0.01	0.75	-0.41	0.91	-0.21	-0.84	0.46	0.95	0.82	-0.85	0.93	0.11	0.91
Other Liab	0.68	-0.5	0.76	0.7	0.82		0.95	0.72	-0.57	-0.96	-0.38	0.51	0.7	-0.27	0.39	-0.83	0.51	-0.52	-1.0	0.78	0.81	0.95	-0.97	0.95	-0.16	0.52
Net Tangible Assets	0.83	-0.39	0.59	0.52	0.94	0.95		0.63	-0.76	-0.84	-0.4	0.71	0.61	-0.04	0.6	-0.63	0.71	-0.42	-0.96	0.64	0.91	0.9	-0.97	1.0	-0.05	0.71
Property Plant And Equipment Net	0.61	0.05	0.86	0.91	0.6	0.72	0.63		-0.48	-0.7	0.3	0.46	1.0	-0.58	0.47	-0.62	0.46	-0.46	-0.67	0.87	0.74	0.81	-0.56	0.63	0.4	0.46
Net Debt	-0.96	-0.23	-0.22	-0.25	-0.94	-0.57	-0.76	-0.48		0.34	-0.02	-1.0	-0.47	-0.12	-0.88	0.09	-1.0	-0.03	0.59	-0.25	-0.89	-0.62	0.61	-0.76	-0.33	-1.0
Retained Earnings	-0.47	0.61	-0.84	-0.78	-0.64	-0.96	-0.84	-0.7	0.34		0.37	-0.28	-0.68	0.4	-0.17	0.94	-0.28	0.54	0.95	-0.84	-0.65	-0.92	0.91	-0.84	0.28	-0.29
Accounts Payable	-0.05	0.82	0.14	0.28	-0.2	-0.38	-0.4	0.3	-0.02	0.37		0.09	0.32	-0.41	0.15	0.31	0.09	0.44	0.42	0.05	-0.06	-0.11	0.53	-0.41	0.65	0.08
Cash	0.95	0.3	0.19	0.23	0.91	0.51	0.71	0.46	-1.0	-0.28	0.09		0.45	0.12	0.88	-0.03	1.0	0.09	-0.54	0.21	0.86	0.58	-0.55	0.7	0.36	1.0
Non Current Assets Total	0.6	0.07	0.85	0.9	0.58	0.7	0.61	1.0	-0.47	-0.68	0.32	0.45		-0.58	0.46	-0.6	0.45	-0.47	-0.64	0.86	0.73	0.78	-0.54	0.61	0.43	0.45
Non Currrent Assets Other	0.01	-0.16	-0.57	-0.77	-0.01	-0.27	-0.04	-0.58	-0.12	0.4	-0.41	0.12	-0.58		0.34	0.62	0.12	0.28	0.25	-0.42	-0.01	-0.36	0.12	-0.04	0.12	0.11
Other Assets	0.84	0.27	0.2	0.14	0.75	0.39	0.6	0.47	-0.88	-0.17	0.15	0.88	0.46	0.34		0.15	0.88	0.05	-0.38	0.31	0.85	0.46	-0.39	0.6	0.67	0.88
Long Term Debt	-0.22	0.59	-0.81	-0.8	-0.41	-0.83	-0.63	-0.62	0.09	0.94	0.31	-0.03	-0.6	0.62	0.15		-0.03	0.55	0.82	-0.75	-0.39	-0.79	0.76	-0.63	0.45	-0.04
Cash And Short Term Investments	0.95	0.3	0.19	0.23	0.91	0.51	0.71	0.46	-1.0	-0.28	0.09	1.0	0.45	0.12	0.88	-0.03		0.09	-0.54	0.21	0.86	0.58	-0.55	0.7	0.36	1.0
Common Stock Shares Outstanding	-0.23	0.41	-0.33	-0.33	-0.21	-0.52	-0.42	-0.46	-0.03	0.54	0.44	0.09	-0.47	0.28	0.05	0.55	0.09		0.49	-0.45	-0.27	-0.31	0.49	-0.42	0.07	0.09
Non Current Liabilities Total	-0.69	0.5	-0.71	-0.66	-0.84	-1.0	-0.96	-0.67	0.59	0.95	0.42	-0.54	-0.64	0.25	-0.38	0.82	-0.54	0.49		-0.72	-0.8	-0.94	0.99	-0.96	0.22	-0.55
Capital Lease Obligations	0.37	-0.37	0.97	0.88	0.46	0.78	0.64	0.87	-0.25	-0.84	0.05	0.21	0.86	-0.42	0.31	-0.75	0.21	-0.45	-0.72		0.64	0.84	-0.63	0.64	0.19	0.21
Other Current Assets	0.94	-0.05	0.57	0.53	0.95	0.81	0.91	0.74	-0.89	-0.65	-0.06	0.86	0.73	-0.01	0.85	-0.39	0.86	-0.27	-0.8	0.64		0.84	-0.79	0.91	0.35	0.87
Other Stockholder Equity	0.68	-0.33	0.86	0.82	0.82	0.95	0.9	0.81	-0.62	-0.92	-0.11	0.58	0.78	-0.36	0.46	-0.79	0.58	-0.31	-0.94	0.84	0.84		-0.88	0.9	-0.03	0.59
Total Liab	-0.7	0.55	-0.59	-0.53	-0.85	-0.97	-0.97	-0.56	0.61	0.91	0.53	-0.55	-0.54	0.12	-0.39	0.76	-0.55	0.49	0.99	-0.63	-0.79	-0.88		-0.97	0.27	-0.56
Net Invested Capital	0.83	-0.4	0.59	0.52	0.93	0.95	1.0	0.63	-0.76	-0.84	-0.41	0.7	0.61	-0.04	0.6	-0.63	0.7	-0.42	-0.96	0.64	0.91	0.9	-0.97		-0.05	0.71
Property Plant And Equipment Gross	0.33	0.63	0.08	0.09	0.11	-0.16	-0.05	0.4	-0.33	0.28	0.65	0.36	0.43	0.12	0.67	0.45	0.36	0.07	0.22	0.19	0.35	-0.03	0.27	-0.05		0.35
Total Current Assets	0.95	0.29	0.19	0.23	0.91	0.52	0.71	0.46	-1.0	-0.29	0.08	1.0	0.45	0.11	0.88	-0.04	1.0	0.09	-0.55	0.21	0.87	0.59	-0.56	0.71	0.35

Click cells to compare fundamentals

Xilio Development Account Relationship Matchups

Pair Trading with Xilio Development

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xilio Development position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will appreciate offsetting losses from the drop in the long position's value.

Moving against Xilio Stock

0.65	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.65	MTEM	Molecular Templates	Pair Corr
0.63	TPST	Tempest Therapeutics	Pair Corr
0.56	ME	23Andme Holding	Pair Corr
0.55	IPSC	Century Therapeutics	Pair Corr

The ability to find closely correlated positions to Xilio Development could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xilio Development when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xilio Development - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xilio Development to buy it.

The correlation of Xilio Development is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xilio Development moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xilio Development moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Xilio Development can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Xilio Development offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Xilio Development's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xilio Development Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xilio Development Stock:

How To Invest In Xilio

Details

Is Xilio Stock a good investment?

Details

What is Xilio Development's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.

You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xilio Development. If investors know Xilio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xilio Development listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.55)

Revenue Per Share

0.105

Return On Assets

(0.53)

Return On Equity

(1.71)

The market value of Xilio Development is measured differently than its book value, which is the value of Xilio that is recorded on the company's balance sheet. Investors also form their own opinion of Xilio Development's value that differs from its market value or its book value, called intrinsic value, which is Xilio Development's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xilio Development's market value can be influenced by many factors that don't directly affect Xilio Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Xilio Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xilio Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xilio Development's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Xilio Historical Balance Sheet

About Xilio Balance Sheet Analysis

Xilio Development Balance Sheet Chart

Total Current Liabilities

Xilio Development balance sheet Correlations

Xilio Development Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pair Trading with Xilio Development

Moving against Xilio Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Invested Capital	+ 1.0	Net Tangible Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Liab	+ 0.99	Non Current Liabilities Total

Total Current Assets	- 1.0	Net Debt
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Non Current Liabilities Total	- 1.0	Other Liab
Net Invested Capital	- 0.97	Total Liab
Total Liab	- 0.97	Net Tangible Assets